Lapatinib
N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine
Molecular Identity
Lapatinib
N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine
PubChem CID: 208908
Lapatinib is a member of furans, an organochlorine compound, an organofluorine compound and a member of quinazolines. It has a role as an antineoplastic agent and a tyrosine kinase inhibitor. It is functionally related to a monofluorobenzene.
2D Structure
Properties
C29H26ClFN4O4S
Molecular Formula
581.10
Molecular Weight
g/mol
580.1347
Exact Mass
Da
5.1
XLogP
Above Lipinski threshold
115
TPSA
Good oral absorption (< 140 A²)
2
H-Bond Donors
9
H-Bond Acceptors
898
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
Lapatinib231277-92-2GW572016GW 572016GW-572016GSK 572016N-{3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}-6-(5-{[(2-methanesulfonylethyl)amino]methyl}furan-2-yl)quinazolin-4-amineGSK-572016DTXSID7046675n-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-4-quinazolinamine0VUA21238FGW-572016XDTXCID5026675CHEBI:496034-Quinazolinamine, N-(3-chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Lapatinib
Loading drug network...